Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
3430 | 1911 | 44.4 | 92% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | RHO KINASE | Author keyword | 190 | 38% | 21% | 400 |
2 | FASUDIL | Author keyword | 175 | 65% | 9% | 166 |
3 | MYOSIN PHOSPHATASE | Author keyword | 81 | 69% | 4% | 70 |
4 | MYPT1 | Author keyword | 56 | 80% | 2% | 35 |
5 | Y 27632 | Author keyword | 55 | 45% | 5% | 90 |
6 | CPI 17 | Author keyword | 44 | 63% | 2% | 45 |
7 | CA2 SENSITIZATION | Author keyword | 44 | 54% | 3% | 56 |
8 | MYOSIN LIGHT CHAIN PHOSPHATASE | Author keyword | 27 | 49% | 2% | 40 |
9 | RHO KINASE INHIBITOR | Author keyword | 24 | 49% | 2% | 36 |
10 | HA1077 | Author keyword | 22 | 81% | 1% | 13 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | RHO KINASE | 190 | 38% | 21% | 400 | Search RHO+KINASE | Search RHO+KINASE |
2 | FASUDIL | 175 | 65% | 9% | 166 | Search FASUDIL | Search FASUDIL |
3 | MYOSIN PHOSPHATASE | 81 | 69% | 4% | 70 | Search MYOSIN+PHOSPHATASE | Search MYOSIN+PHOSPHATASE |
4 | MYPT1 | 56 | 80% | 2% | 35 | Search MYPT1 | Search MYPT1 |
5 | Y 27632 | 55 | 45% | 5% | 90 | Search Y+27632 | Search Y+27632 |
6 | CPI 17 | 44 | 63% | 2% | 45 | Search CPI+17 | Search CPI+17 |
7 | CA2 SENSITIZATION | 44 | 54% | 3% | 56 | Search CA2+SENSITIZATION | Search CA2+SENSITIZATION |
8 | MYOSIN LIGHT CHAIN PHOSPHATASE | 27 | 49% | 2% | 40 | Search MYOSIN+LIGHT+CHAIN+PHOSPHATASE | Search MYOSIN+LIGHT+CHAIN+PHOSPHATASE |
9 | RHO KINASE INHIBITOR | 24 | 49% | 2% | 36 | Search RHO+KINASE+INHIBITOR | Search RHO+KINASE+INHIBITOR |
10 | HA1077 | 22 | 81% | 1% | 13 | Search HA1077 | Search HA1077 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CA2 SENSITIZATION | 220 | 57% | 14% | 260 |
2 | LIGHT CHAIN PHOSPHATASE | 160 | 57% | 10% | 191 |
3 | MYOSIN PHOSPHATASE | 153 | 40% | 15% | 296 |
4 | FASUDIL | 89 | 66% | 4% | 82 |
5 | CALCIUM SENSITIZATION | 79 | 61% | 4% | 84 |
6 | RHO ASSOCIATED KINASE | 69 | 30% | 10% | 194 |
7 | MYOSIN LIGHT CHAIN | 52 | 26% | 9% | 169 |
8 | RHO KINASE | 51 | 17% | 14% | 271 |
9 | LONG TERM INHIBITION | 50 | 48% | 4% | 77 |
10 | MEDIATED CA2 SENSITIZATION | 47 | 66% | 2% | 43 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Rho kinases in cardiovascular physiology and pathophysiology | 2006 | 290 | 123 | 65% |
Rho-Kinase/ROCK: A Key Regulator of the Cytoskeleton and Cell Polarity | 2010 | 152 | 112 | 48% |
Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: Modulated by G proteins, kinases, and myosin phosphatase | 2003 | 1102 | 410 | 39% |
Rho-kinase is an important therapeutic target in cardiovascular medicine | 2005 | 278 | 91 | 75% |
The Rho Kinases: Critical Mediators of Multiple Profibrotic Processes and Rational Targets for New Therapies for Pulmonary Fibrosis | 2015 | 2 | 137 | 34% |
Rho-associated coiled-coil-forming kinases (ROCKs): potential targets for the treatment of atherosclerosis and vascular disease | 2011 | 58 | 71 | 69% |
Development of Rho-kinase inhibitors for cardiovascular medicine | 2007 | 121 | 50 | 90% |
Rho-kinase: important new therapeutic target in cardiovascular diseases | 2011 | 81 | 136 | 47% |
Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells | 2001 | 477 | 55 | 78% |
Rocks: Multifunctional kinases in cell behaviour | 2003 | 904 | 142 | 36% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MUSCLE BIOL GRP | 13 | 28% | 2.0% | 38 |
2 | CELL PHARMACOL | 6 | 14% | 2.1% | 40 |
3 | SMOOTH MUSCLE GRP | 5 | 13% | 2.0% | 38 |
4 | VASC MED UNIT | 5 | 15% | 1.5% | 29 |
5 | TECHNOL AGCY | 3 | 43% | 0.3% | 6 |
6 | COE PROGRAM LIFESTYLE RELATED DIS | 3 | 31% | 0.4% | 8 |
7 | CANADIAN HLTH GRP REGULAT VASC CONTRACTI | 2 | 44% | 0.2% | 4 |
8 | ANGIOCARDIOL | 2 | 12% | 0.9% | 18 |
9 | FRONTIER 21 PROJECT | 2 | 67% | 0.1% | 2 |
10 | PROGRAM CELL DEV BIOL DENT | 2 | 67% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000127784 | FORCE MAINTENANCE//HEAT SHOCK PROTEIN 20//ACTIVATION CONTRACTION COUPLING |
2 | 0.0000118960 | 1 5 ISOQUINOLINESULFONYL 2 METHYLPIPERAZINE//12 DEOXYPHORBOL 13 ISOBUTYRATE//DIACYLGLYCEROL ANALYSIS |
3 | 0.0000108553 | PKN//PROTEIN KINASE C RELATED KINASE//PRK1 |
4 | 0.0000099238 | TIAM1//RHOB//RHOGDI2 |
5 | 0.0000086384 | RATIOMETRIC FLUORESCENCE ANALYSIS//GENISTEIN INHIBITION//ISOBESTIC FLUORESCENCE ANALYSIS |
6 | 0.0000082172 | G ALPHA12//G ALPHA16//G ALPHA 16 |
7 | 0.0000078097 | CATCH MUSCLE//MYOROD//UNIT MOL CELLULAR BIOL |
8 | 0.0000075678 | CALDESMON//CALPONIN//MYOPODIN |
9 | 0.0000068114 | TYPE II CGMP DEPENDENT PROTEIN KINASE//CGMP DEPENDENT PROTEIN KINASE//CANC MOL BIOL SECT |
10 | 0.0000056962 | SECT PULM CRIT MED//LUNG INJURY//ENDOTHELIAL PERMEABILITY |